MASS SPECTROMETRY
technique to a streamlined, automated process, it can take its place alongside other routine testing methods in delivering precise, timely insights for patient care.
Looking ahead
At Roche Diagnostics, we see the potential for mass spectrometry to become a routine tool in the delivery of diagnostics, supporting clinicians and patients with the information they need, when they need it. Our goal is to break down the barriers that have limited the use of this valuable technology, ensuring it is accessible to more laboratories across the UK and Ireland, regardless of their size or existing expertise in mass spectrometry. As we prepare to showcase the cobas Mass Spec solution at IBMS Congress 2025, we invite laboratory leaders, healthcare scientists and clinicians to explore how automated mass spectrometry could support their diagnostic services. Whether it’s expanding your test portfolio, improving turnaround times, or supporting personalised care pathways, we believe the potential for mass spectrometry to make a difference in routine diagnostics is significant. We look forward to joining colleagues across the sector in this conversation
about how we can continue to innovate together to meet the needs of patients and healthcare systems today, and in the years to come.
References 1 Department of Health and Social Care.
Fit for the Future: The 10 Year Health Plan for England. (
Gov.uk, 2025)
www.gov.uk/ government/publications/10-year-health- plan-for-england-fit-for-the-future
2 Kasapić D. Fuelling a new era of innovation in mass spectrometry. (
Healthcaretransformers.com, 2023) www.
healthcaretransformers.com/healthcare- business/strategy-and-operations/mass- spectrometry-testing-integration/
3 Wong J. The prospects of clinical mass spectrometry: A case study from Singapore General Hospital. (Roche Lab Leaders, 2024)
www.lableaders.roche.com/global/ en/articles/clinical-mass-spectrometry-in-
the-laboratory.html
4 Rankin-Turner S, Heaney LM. Mass spectrometry in the clinical laboratory. A short journey through the contribution to the scientific literature by CCLM. Clin Chem Lab Med. 2022 Oct 26;61(5):873- 879. doi:10.1515/cclm-2022-0984
5 Hristova J, Svinarov D. Enhancing precision medicine through clinical mass spectrometry platform. Biotechnology & Biotechnological Equipment. 2022 Mar 23;
36(1):107-117, doi:10.1080/13102818.202 2.2053342
6 Lilienfeld B. Dr. Benjamin Lilienfeld discusses Roche mass spectrometry solution launch. (Roche Diagnostics Schweiz, 2025)
www.selectscience.net/ article/dr-benjamin-lilienfeld-discusses- cobas-r-mass-spectrometry-solution-launch
7 Roche Diagnostics. White paper: Fuelling a new era of innovation in mass spectrometry. (Roche, 2025)
https://diagnostics.roche.com/content/ dam/acadia/whitepaper/217/768/ MC-UK-01306%20cobas%20Mass%20 Spec%20Whitepaper%2004LA.pdf
8 Ketha SS, Singh RJ, Ketha H. Role of Mass Spectrometry in Clinical Endocrinology. Endocrinol Metab Clin North Am. 2017 Sep;46(3):593-613. doi:10.1016/
j.ecl.2017.04.001
Joanne Bradley is Regional Product Manager, Roche Diagnostics UK&I.
For further insights on the cobas Mass Spec solution, or to connect with the Roche Diagnostics UK&I team ahead of IBMS Congress 2025, visit
diagnostics.roche. com or join us at our stand to see how automated mass spectrometry could shape the future of your laboratory.
www.diagnostics.roche.com
WWW.PATHOLOGYINPRACTICE.COM AUGUST 2025
63
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72
